AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H2342-H2349, 2005. First published July 29, 2005; doi:10.1152/ajpheart.00511.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/H2342    most recent
00511.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohlmann, P.
Right arrow Articles by Andriantsitohaina, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohlmann, P.
Right arrow Articles by Andriantsitohaina, R.

Deletion of MLCK210 induces subtle changes in vascular reactivity but does not affect cardiac function

Patrick Ohlmann,1 Angela Tesse,1 Cécile Loichot,1 Hantamalala Ralay Ranaivo,2 Gerald Roul,1 Claude Philippe,3 D. Martin Watterson,2 Jacques Haiech,3 and Ramaroson Andriantsitohaina3

UMR Centre National de la Recherche Scientifique 17034 and 37081, Université Louis Pasteur, Illkirch, France; and 2Center for Drug Discovery and Chemical Biology, Northwestern University, Chicago, Illinois

Submitted 7 June 2004 ; accepted in final form 6 July 2005

Myosin light chain kinase (MLCK) plays a key role in the regulation of actomyosin contraction in a large variety of cells. Two isoforms have been described: a short isoform, widely expressed in smooth muscle cells; and a long isoform (MLCK210), mainly localized in the endothelium. This study investigated the consequences on different cardiovascular parameters of MLCK210 gene deletion using MLCK210 knockout mice and of pharmacological inhibition of the kinase using a specific MLCK inhibitor. Deletion of MLCK210 did not affect systolic blood pressure and heart rate or echocardiographic measurements. Electrocardiographic analysis showed neither atrio- nor intraventricular conduction or repolarization defects. Ex vivo responses of aortic rings to vasoconstrictor and vasodilator agonists were not modified in MLCK210 null mice. However, deletion of MLCK210 attenuated shear stress-induced dilation and produced changes in the balance of endothelial-relaxing factors of small mesenteric arteries (SMA). In particular, a reduced flow-mediated NO-dependent dilation was observed. However, it was partially compensated by enhanced indomethacin-sensitive dilation. No significant changes were detected in the endothelium-derived hyperpolarizing component of the vasodilator response. The above effects of MLCK210 gene deletion were confirmed in SMA from wild-type mice by the use of the MLCK enzymatic inhibitor MMZ-10–057. In summary, deletion of MLCK210 was not associated with abnormalities of main in vivo cardiovascular parameters in mice. This study demonstrates a role for MLCK210 in the regulation of flow-dependent dilation in SMA.

myosin light chain kinase 210; knockout mice; echocardiography; endothelium; vascular reactivity; shear stress



Address for reprint requests and other correspondence: R. Andriantsitohaina, UMR CNRS 7081, Faculté de Pharmacie, 74, route du Rhin, 67401 Illkirch, France (e-mail: ramaroson.andriantsitohaina{at}pharma.u-strasbg.fr)




This article has been cited by other articles:


Home page
Circ. Res.Home page
Y. Ishikawa and R. Kurotani
Cardiac Myosin Light Chain Kinase: A New Player in the Regulation of Myosin Light Chain in the Heart
Circ. Res., March 14, 2008; 102(5): 516 - 518.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Y. Chan, M. Takeda, L. E. Briggs, M. L. Graham, J. T. Lu, N. Horikoshi, E. O. Weinberg, H. Aoki, N. Sato, K. R. Chien, et al.
Identification of Cardiac-Specific Myosin Light Chain Kinase
Circ. Res., March 14, 2008; 102(5): 571 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Tesse, G. Al-Massarani, R. Wangensteen, S. Reitenbach, M. C. Martinez, and R. Andriantsitohaina
Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist, Prevents Microparticle-Induced Vascular Hyporeactivity through the Regulation of Proinflammatory Proteins
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. P. Herring, O. El-Mounayri, P. J. Gallagher, F. Yin, and J. Zhou
Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C817 - C827.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.